Evidence map›Paper›PMID 18949356›Full record

ArticleInternational journal of oncology2008

uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo.

Odysseas Kargiotis, Chandramu Chetty, Venkateswara Gogineni, Christopher S Gondi, Sai Muralikrishna Pulukuri, Athanassios P Kyritsis, Meena Gujrati, Jeffrey D Klopfenstein, Dzung H Dinh, Jasti S Rao

Open access · bronzeAbstract read
In one paragraph

Article in International journal of oncology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Preclinical Models of Meningioma.Advances in experimental medicine and biology · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Effects of radiation on the metastatic process.Molecular medicine (Cambridge, Mass.) · 2018
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Oncology letters · 2014
    Article
  15. Review
  16. Tumor stroma as targets for cancer therapy.Pharmacology & therapeutics · 2013
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Odysseas KargiotisDepartment of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, IL 61605, USA.
Chandramu Chetty
Venkateswara Gogineni
Christopher S Gondi
Sai Muralikrishna Pulukuri
Athanassios P Kyritsis
Meena Gujrati
Jeffrey D Klopfenstein
Dzung H Dinh
Jasti S Rao
Peoria campus of the University of Illinois System · US

Funding

Cath B and uPAR si RNA constructs regressed glioma growthR01CA116708 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI O'BRYAN, JOHN P · 2005 to 2014
$2.9M
Inhibition of glioma tumor growth by antisense MMP-9R01NS047699 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RAO, JASTI S. · 2003 to 2011
$2.5M
Role of uPA and uPAR in Human Glioma InvasivenessR01CA075557 · NCI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI RAO, JASTI S. · 1998 to 2009
$2.3M
Growth inhibition of brain tumors by cord blood stem cellsR01NS057529 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RAO, JASTI S. · 2006 to 2010
$1.8M
Regression of meningioma tumor growth by combination therapyR01NS061835 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RAO, JASTI S. · 2008 to 2012
$1.7M
Role of TFPI-2 in human gliomas invasivenessR01CA095058 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RAO, JASTI S. · 2003 to 2007
$1.5M
Suppression of glioma invasion by a bicistronic constuctR01CA092393 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RAO, JASTI S. · 2003 to 2007
$1.4M
NCI NIH HHS CA 116708NCI NIH HHS CA 75557NCI NIH HHS CA 92393NCI NIH HHS CA 95058NCI NIH HHS R01 CA075557NCI NIH HHS R01 CA092393NCI NIH HHS R01 CA095058NCI NIH HHS R01 CA116708NINDS NIH HHS NS47699NINDS NIH HHS NS57529NINDS NIH HHS NS61835NINDS NIH HHS R01 NS047699NINDS NIH HHS R01 NS057529NINDS NIH HHS R01 NS061835
6 · The paper itself

Abstract

Meningioma is a well-known tumor of the central nervous system, and is treated by surgical resection and/or radiation. Recently, ionizing radiation has been shown to enhance invasiveness of surviving tumor cells, and several proteolytic enzyme molecules, including urokinase plasminogen activator (uPA), seem to be upregulated after radiation. uPA and its receptor (uPAR) have been strongly implicated in tumor invasion, angiogenesis and progression. Hence, the tumor-associated uPA-uPAR system is considered a potential target for cancer therapy. In the present study, we show that radiation increases uPA levels in the IOMM-Lee meningioma cells, and subsequently, increases tumor invasion, migration and angiogenesis in vitro. Studies with signaling molecule inhibitors AG1478, U0126 and SB203580 (specific inhibitors of EGFR, MEK1/2 and p38 respectively) showed inhibition of uPA levels in both basal and irradiated-IOMM-Lee cells. The PI3K inhibitor (LY294002) and the AKT inhibitor (AKT inhibitor IV) also partially decreased uPA expression, whereas SP600125, a JNK inhibitor, did not affect uPA levels in either radiated or non-radiated cells. Further, a bicistronic plasmid construct with small interfering RNA (siRNA) against uPA and its receptor inhibited tumor invasion, migration and angiogenesis in radiation-treated IOMM-Lee cells. In addition, siRNA against uPA and its receptor inhibited subcutaneous tumor growth in athymic nude mice in combination with radiation in a synergistic manner. Thus, the specific targeting of proteases via RNA interference could augment the therapeutic effect of radiation and prevent the adverse effects resulting from tumor cells that receive sublethal doses of radiation within the tumor mass.

Indexed as

RNA InterferenceAnimalsCapillariesCell Line, TumorCell MovementCell ProliferationDown-RegulationErbB ReceptorsExtracellular Signal-Regulated MAP KinasesFemaleGenetic TherapyHumansMeningeal NeoplasmsMeningiomaMiceMice, NudeEGFR protein, humanErbB ReceptorsExtracellular Signal-Regulated MAP Kinasesp38 Mitogen-Activated Protein KinasesProtein Kinase InhibitorsReceptors, Urokinase Plasminogen ActivatorRNA, Small InterferingUrokinase-Type Plasminogen Activator

Identifiers

PMID18949356
PMCPMC2575644
OpenAlexW2100465595

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.